Outcome of major hepatectomy in cirrhotic patients; does surgical approach matter? A propensity score matched analysis.


Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 12 10 2021
received: 23 07 2021
accepted: 27 10 2021
pubmed: 3 12 2021
medline: 22 11 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Major hepatectomy in cirrhotic patients still represents a great challenge for liver surgeons. Hence, the aim in the present study is to investigate the clinical impact of major hepatectomy and to assess whether the surgical approach influences the outcome of cirrhotic patients. Multicenter retrospective study including cirrhotic patients undergoing major laparoscopic (mjLLR) and open liver resection (mjOLR) in 14 Western liver centers was performed (2009-2020). Clinical, demographic, and perioperative data were compared using propensity score matching (PSM). Long-term outcome after resection for hepatocellular carcinoma was analyzed. Overall, 352 patients were included; 108 after mjLLR and 244 after mjOLR. After PSM, 88 patients were matched in each group. In the mjLLR group, compared to mjOLR, less blood loss (P = .042), lower overall and severe complication (P < .001, .020), such as surgical site infection, acute kidney injury and liver failure were observed, parallel to a shorter length of hospital stay. Stratifying patients based on the type of resection, less severe complications was observed only after laparoscopic left hepatectomy (P = .044), while the advantages of laparoscopy tend to decrease during right hepatectomy. Subgroup analysis of long-term survivals following liver resection for hepatocellular carcinoma showed no difference between mjLLR and mjOLR. This multicenter experience suggests potential short-term benefits of mjLLR in cirrhotic patients compared to mjOLR, without compromising long-term outcome. These findings might have interesting clinical implications for the management of patients with chronic liver disease.

Identifiants

pubmed: 34855277
doi: 10.1002/jhbp.1087
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1226-1239

Informations de copyright

© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Références

Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835-53.
European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182-236.
Scatton O, Goumard C, Cauchy F, Fartoux L, Perdigao F, Conti F, et al. Early and resectable HCC: Definition and validation of a subgroup of patients who could avoid liver transplantation. J Surg Oncol. 2015;111(8):1007-15.
Hobeika C, Fuks D, Cauchy F, Goumard C, Soubrane O, Gayet B, et al. Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey. Br J Surg. 2020;107(3):268-77.
Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;240(1):102-7.
Mouiel J, Katkhouda N, Gugenheim J, Fabiani P. Possibilities of laparoscopic liver resection. J Hepatobiliary Pancreat Surg. 2000;7(1):1-8.
Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250(5):825-30.
Di Sandro S, Bagnardi V, Najjar M, Buscemi V, Lauterio A, De Carlis R, et al. Minor laparoscopic liver resection for hepatocellular carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: propensity score analysis. Surg Oncol. 2018;27(4):722-9.
Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, et al. The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg. 2018;268(1):11-8.
Chan A, Kow A, Hibi T, Di Benedetto F, Serrablo A. Liver resection in cirrhotic liver: are there any limits? Int J Surg. 2020;82S:109-14.
Morise Z, Ciria R, Cherqui D, Chen KH, Belli G, Wakabayashi G. Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci. 2015;22(5):342-52.
Kim WJ, Kim KH, Kim SH, Kang WH, Lee SG. Laparoscopic versus open liver resection for centrally located hepatocellular carcinoma in patients with cirrhosis: a propensity score-matching analysis. Surg Laparosc Endosc Percutan Tech. 2018;28(6):394-400.
van der Heijde N, Ratti F, Aldrighetti L, Benedetti Cacciaguerra A, Can MF, D'Hondt M, et al. Laparoscopic versus open right posterior sectionectomy: an international, multicenter, propensity score-matched evaluation. Surg Endosc. 2021;35(11):6139-6149.
Levi Sandri GB, Lai Q, Ravaioli M, Di Sandro S, Balzano E, Pagano D, et al. The role of salvage transplantation in patients initially treated with open versus minimally invasive liver surgery: an intention-to-treat analysis. Liver Transpl. 2020;26(7):878-87.
Ciria R, Gomez-Luque I, Ocaña S, Cipriani F, Halls M, Briceño J, et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for hepatocellular carcinoma: updated results from the European guidelines meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017. Ann Surg Oncol. 2019;26(1):252-63.
Yoon Y-I, Kim K-H, Kang S-H, Kim W-J, Shin M-H, Lee S-K, et al. Pure laparoscopic versus open right hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score matched analysis. Ann Surg. 2017;265(5):856-63.
Wu X, Huang Z, Lau WY, Li W, Lin P, Zhang L, et al. Perioperative and long-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with well-preserved liver function and cirrhotic background: a propensity score matching study. Surg Endosc. 2019;33(1):206-15.
Xu HW, Liu F, Li HY, Wei YG, Li B. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis. Surg Endosc. 2018;32(2):712-9.
Ko GY, Hwang S, Sung KB, Gwon DI, Lee SG. Interventional oncology: new options for interstitial treatments and intravascular approaches: right hepatic vein embolization after right portal vein embolization for inducing hypertrophy of the future liver remnant. J Hepatobiliary Pancreat Sci. 2010;17(4):410-2.
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329-38.
Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351-5.
Pearce NW, Di Fabio F, Abu HM. Laparoscopic left hepatectomy with extraparenchymal inflow control. J Am Coll Surg. 2011;213(5):e23-7.
Benedetti Cacciaguerra A, Görgec B, Cipriani F, Aghayan D, Borelli G, Aljaiuossi A, et al. Risk factors of positive resection margin in laparoscopic and open liver surgery for colorectal liver metastases: a new perspective in the perioperative assessment: a European multicenter study. Ann Surg. 2020; (Ahead of print)
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13.
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149(5):680-8.
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713-24.
Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249(4):617-23.
Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamazoe S, Yamamoto S, et al. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc. 2013;27(7):2592-7.
Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol. 2015;63(3):643-50.
Lopez-Delgado JC, Ballus J, Esteve F, Betancur-Zambrano NL, Corral-Velez V, Mañez R, et al. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol. 2016;22(9):2657-67.
Lim C, Audureau E, Salloum C, Levesque E, Lahat E, Merle JC, et al. Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value. HPB. 2016;18(6):540-8.
Morise Z, Aldrighetti L, Belli G, Ratti F, Belli A, Cherqui D, et al. Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg. 2020;107(7):889-95.
Mazzaferro V, Citterio D, Bhoori S, Bongini M, Miceli R, De Carlis L, et al. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial. Lancet Oncol. 2020;21(7):947-56.
Wakabayashi T, Benedetti Cacciaguerra A, Ciria R, Ariizumi S, Durán M, Golse N, et al. Landmarks to identify segmental borders of the liver: a review prepared for PAM-HBP expert consensus meeting 2021. J Hepatobiliary Pancreat Sci. 2021; (Ahead of print)
Sunagawa Y, Yamada S, Kato Y, Sonohara F, Takami H, Inokawa Y, et al. Perioperative assessment of indocyanine green elimination rate accurately predicts postoperative liver failure in patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci. 2021;28(1):86-94.
Le Roy B, Gregoire E, Cosse C, Serji B, Golse N, Adam R, et al. Indocyanine green retention rates at 15 min predicted hepatic decompensation in a western population. World J Surg. 2018;42(8):2570-8.

Auteurs

Andrea Benedetti Cacciaguerra (A)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.
Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Department of Experimental and Clinical Medicine, Hepatobiliary and Abdominal Transplantation Surgery, Riuniti Hospital, Polytechnic University of Marche, Ancona, Italy.

Burak Görgec (B)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.
Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jacopo Lanari (J)

Hepatobiliary Surgery and Liver Transplantation Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Nadia Russolillo (N)

Department of General and Oncological Surgery, Umberto I Mauriziano Hospital, Turin, Italy.

Federico Mocchegiani (F)

Department of Experimental and Clinical Medicine, Hepatobiliary and Abdominal Transplantation Surgery, Riuniti Hospital, Polytechnic University of Marche, Ancona, Italy.

Giuseppe Zimmitti (G)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.

Adnan Alseidi (A)

Department of Surgery, Virginia Mason Medical Center, Seattle, Washington, USA.
Department of Surgery, University of California San Francisco, San Francisco, California, USA.

Andrea Ruzzenente (A)

Department of Surgery, University of Verona, Verona, Italy.

Bjorn Edwin (B)

The Intervention Centre and Department of HPB surgery, Institute of Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Felice Giuliante (F)

Chirurgia Epatobiliare, Università Cattolica del Sacro Cuore-IRCCS, Rome, Italy.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, Université Paris Descartes, Paris, France.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, Department of General and Digestive Surgery, Clínica Universidad de Navarra, Pamplona, Spain.

Santiago López-Ben (S)

Servei de Cirurgia General i Digestiva, Hospital Doctor Josep Trueta de Girona, Girona, Spain.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Umberto I Mauriziano Hospital, Turin, Italy.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Umberto Cillo (U)

Hepatobiliary Surgery and Liver Transplantation Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.

Marco Vivarelli (M)

Department of Experimental and Clinical Medicine, Hepatobiliary and Abdominal Transplantation Surgery, Riuniti Hospital, Polytechnic University of Marche, Ancona, Italy.

Mohammed Abu Hilal (M)

Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.
Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH